Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.
作者信息
Schalm S W
机构信息
Department of Hepatogastroenterology, Erasmus University Hospital Rotterdam - Dijkzigt, PO Box 2040, 3000 CA Rotterdam, The Netherlands (email:
出版信息
Gut. 1998 Nov;43(5):602. doi: 10.1136/gut.43.5.602.
Abstract
摘要
相似文献
1
Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.对于慢性丙型肝炎感染，在干扰素α-2b基础上加用利巴韦林可提高病毒学应答率，但会增加恶心症状。
Gut. 1998 Nov;43(5):602. doi: 10.1136/gut.43.5.602.
2
Sustained virological response after a short course of treatment with interferon and ribavirin in two chronic hepatitis C patients.两名慢性丙型肝炎患者接受干扰素和利巴韦林短疗程治疗后的持续病毒学应答
J Hepatol. 2003 Oct;39(4):655-6. doi: 10.1016/s0168-8278(03)00403-3.
3
Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.干扰素-α-2b 加利巴韦林：关于其在慢性丙型肝炎治疗中应用的综述
Drugs. 2002;62(3):507-56. doi: 10.2165/00003495-200262030-00009.
4
Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.聚乙二醇干扰素α-2b与利巴韦林联合治疗基因4型慢性丙型肝炎：治疗疗程和病毒动力学对持续病毒学应答的影响
Gut. 2005 Jun;54(6):858-66. doi: 10.1136/gut.2004.057182.
5
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.人类免疫缺陷病毒感染者慢性丙型肝炎的抗病毒治疗
Cochrane Database Syst Rev. 2010 Jan 20(1):CD004888. doi: 10.1002/14651858.CD004888.pub2.
6
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.聚乙二醇干扰素α-2a（40KD）联合利巴韦林加或不加金刚烷胺治疗初治1型慢性丙型肝炎感染患者的随机、双盲、安慰剂对照研究
J Hepatol. 2006 Feb;44(2):275-82. doi: 10.1016/j.jhep.2005.09.015. Epub 2005 Nov 7.
7
Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.
Transplant Proc. 2003 Sep;35(6):2080-1. doi: 10.1016/s0041-1345(03)00681-x.
8
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.干扰素α-2b单独或联合利巴韦林作为慢性丙型肝炎的初始治疗。肝炎介入治疗组。
N Engl J Med. 1998 Nov 19;339(21):1485-92. doi: 10.1056/NEJM199811193392101.
9
High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.高剂量干扰素-α 2b联合利巴韦林治疗GB病毒-C/庚型肝炎病毒感染——一项针对慢性丙型肝炎患者的研究
Hepatogastroenterology. 2003 Mar-Apr;50(50):449-52.
10
Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C.在初治慢性丙型肝炎患者中，干扰素、利巴韦林与金刚烷胺联用对比干扰素、利巴韦林与安慰剂联用的随机、双盲、安慰剂对照试验。
Gut. 2004 Jan;53(1):130-5. doi: 10.1136/gut.53.1.130.
本文引用的文献
1
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.干扰素剂量在慢性丙型肝炎中的疗效及反应预测：比荷卢三国336例患者的研究
J Hepatol. 1998 Jun;28(6):951-9. doi: 10.1016/s0168-8278(98)80342-5.
2
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.慢性丙型肝炎患者经α干扰素治疗获得持续应答后，长期的组织学改善及肝内可检测到的丙型肝炎病毒RNA消失。
Ann Intern Med. 1997 Nov 15;127(10):875-81. doi: 10.7326/0003-4819-127-10-199711150-00003.
Zotero 插件